These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 32380911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H, Granberg T, Westman E, Svenningsson P.
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [Abstract] [Full Text] [Related]

  • 3. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K, Imabayashi E, Tokumaru AM, Ito K, Shimoji K, Nakagawa M, Ozawa Y, Shimohira M, Ogawa M, Morimoto S, Aiba I, Matsukawa N, Shibamoto Y.
    Magn Reson Med Sci; 2017 Jan 10; 16(1):16-22. PubMed ID: 27001391
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S, Frosini D, Costagli M, Del Prete E, Donatelli G, Cecchi P, Migaleddu G, Bonuccelli U, Ceravolo R, Cosottini M.
    Neuroimage Clin; 2019 Jan 10; 24():101999. PubMed ID: 31539801
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C, Acarer A, Guneyli S, Akyuz E, Aydin E, Colakoglu Z, Kitis O, Calli MC.
    Neurol Res; 2019 Feb 10; 41(2):110-117. PubMed ID: 30373485
    [Abstract] [Full Text] [Related]

  • 9. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, Yamada K, Uetani H, Yamashita Y, Wang Y.
    J Neurol Sci; 2019 Nov 15; 406():116443. PubMed ID: 31634718
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnosis of MSA-P and PSP-P in Early Stage].
    Yamawaki T.
    Brain Nerve; 2020 Apr 15; 72(4):331-343. PubMed ID: 32284458
    [Abstract] [Full Text] [Related]

  • 12. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K.
    Parkinsonism Relat Disord; 2018 Jan 15; 46():47-55. PubMed ID: 29126761
    [Abstract] [Full Text] [Related]

  • 13. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
    Bae YJ, Kim JM, Kim E, Lee KM, Kang SY, Park HS, Kim KJ, Kim YE, Oh ES, Yun JY, Kim JS, Jeong HJ, Jeon B, Kim SE.
    Mov Disord; 2016 May 15; 31(5):684-92. PubMed ID: 26990970
    [Abstract] [Full Text] [Related]

  • 14. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
    Chougar L, Arsovic E, Gaurav R, Biondetti E, Faucher A, Valabrègue R, Pyatigorskaya N, Dupont G, Lejeune FX, Cormier F, Corvol JC, Vidailhet M, Degos B, Grabli D, Lehéricy S.
    Mov Disord; 2022 Jun 15; 37(6):1245-1255. PubMed ID: 35347754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun 15; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L, Kassubek J, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Pinkhardt EH, Respondek G, Stamelou M, Möller F, Schnitzler A, Oertel WH, Knake S, Huppertz HJ, Höglinger GU.
    Mov Disord; 2017 May 15; 32(5):778-782. PubMed ID: 28150443
    [Abstract] [Full Text] [Related]

  • 20. Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms.
    Mazzucchi S, Del Prete E, Costagli M, Frosini D, Paoli D, Migaleddu G, Cecchi P, Donatelli G, Morganti R, Siciliano G, Cosottini M, Ceravolo R.
    Eur J Neurol; 2022 Oct 15; 29(10):2944-2955. PubMed ID: 35700041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.